Expertise in
20
conditions

Dr. Jennifer L. Miller

Pediatric Endocrinology | Pediatrics
Florida Clinical Practice Association Inc
1549 Gale Lemerand Dr, Fl 4, 
Gainesville, FL 
Accepting New Patients
Expertise in
20
conditions
Florida Clinical Practice Association Inc
1549 Gale Lemerand Dr, Fl 4, 
Gainesville, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jennifer Miller is a Pediatric Endocrinologist and a Pediatrics provider in Gainesville, Florida. Dr. Miller is highly rated in 20 conditions, according to our data. Her top areas of expertise are Prader-Willi Syndrome, Hypotonia, Obesity, Hormone Replacement Therapy (HRT), and Sleeve Gastrectomy. Dr. Miller is currently accepting new patients.

Her clinical research consists of co-authoring 82 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Florida College Of Medicine
Specialties
Pediatric Endocrinology
Pediatrics
Licenses
Pediatric Endocrinology in FL
Hospital Affiliations
Uf Health Shands Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

FLORIDA CLINICAL PRACTICE ASSOCIATION INC
1549 Gale Lemerand Dr, Fl 4, Gainesville, FL 32610
Other Locations
FLORIDA CLINICAL PRACTICE ASSOCIATION INC
2001 Sw 13th St, Gi Clinic At Endoscopy Center, Gainesville, FL 32608

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2/Phase 3
Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
Phase 3 Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Drug, Other, Genetic
Study Drug: Dichloroacetate (DCA)
Study Phase: Phase 3
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
A Phase 2, Open-Label 20-Week Study to Evaluate the Safety and Efficacy of Setmelanotide in Subjects With Hypothalamic Obesity
Enrollment Status: Completed
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug
Study Drug: DCCR (diazoxide choline controlled release tablets)
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Enrollment Status: Active_not_recruiting
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Pitolisant
Study Phase: Phase 2
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
Enrollment Status: Completed
Publish Date: November 15, 2022
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
Intranasal Oxytocin for Treatment of Infants and Children With Prader-Willi Syndrome in Nutritional Phase 1a - Phase 2 Study
Intranasal Oxytocin for Treatment of Infants and Children With Prader-Willi Syndrome in Nutritional Phase 1a - Phase 2 Study
Enrollment Status: Completed
Publish Date: March 26, 2020
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 10 Less Clinical Trials

82 Total Publications

Pharmacological Aspects in the Management of Children and Adolescents with Prader-Willi Syndrome.
Pharmacological Aspects in the Management of Children and Adolescents with Prader-Willi Syndrome.
Journal: Paediatric drugs
Published: January 05, 2025
Similar Doctors
Expertise in
5
conditions
Dr. Desmond A. Schatz
Pediatric Endocrinology | Pediatrics
Expertise in
5
conditions
Dr. Desmond A. Schatz
Pediatric Endocrinology | Pediatrics
1600 Sw Archer Rd, 
Gainesville, FL 
 (0.4 mi)
352-273-9270
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Desmond Schatz is a Pediatric Endocrinologist and a Pediatrics provider in Gainesville, Florida. Dr. Schatz is highly rated in 5 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Type 2 Diabetes (T2D), and Addison's Disease. Dr. Schatz is currently accepting new patients.

Expertise in
4
conditions
Dr. Michael J. Haller
Pediatric Endocrinology | Pediatrics
Expertise in
4
conditions
Dr. Michael J. Haller
Pediatric Endocrinology | Pediatrics

Florida Clinical Practice Association Inc

1549 Gale Lemerand Dr, Fl 4, 
Gainesville, FL 
 (0.1 mi)
352-265-5240
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Haller is a Pediatric Endocrinologist and a Pediatrics provider in Gainesville, Florida. Dr. Haller is highly rated in 4 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Low Blood Sugar, and Type 2 Diabetes (T2D). Dr. Haller is currently accepting new patients.

Expertise in
2
conditions
Dr. Laura M. Jacobsen
Pediatric Endocrinology | Pediatrics
Expertise in
2
conditions
Dr. Laura M. Jacobsen
Pediatric Endocrinology | Pediatrics
1600 Sw Archer Rd, 
Gainesville, FL 
 (0.4 mi)
352-334-1390
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Laura Jacobsen is a Pediatric Endocrinologist and a Pediatrics provider in Gainesville, Florida. Dr. Jacobsen is highly rated in 2 conditions, according to our data. Her top areas of expertise are Type 1 Diabetes (T1D), Diabetic Ketoacidosis, Type 2 Diabetes (T2D), and Low Blood Sugar. Dr. Jacobsen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Miller's expertise for a condition
ConditionClose
View All 17 Distinguished Conditions
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile